Published in Carcinogenesis on February 01, 1995
Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol (2007) 2.59
Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics (2009) 1.96
Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol (2009) 1.23
Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway. Carcinogenesis (2008) 1.14
Environmental epigenetics in metal exposure. Epigenetics (2011) 1.08
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis (2015) 0.95
Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation. J Cell Physiol (2009) 0.92
Cell size and cancer: a new solution to Peto's paradox? Evol Appl (2014) 0.80
Chemometric methods for studying the relationships between trace elements in laryngeal cancer and healthy tissues. Biol Trace Elem Res (2014) 0.79
Disruptive chemicals, senescence and immortality. Carcinogenesis (2015) 0.78
Syrian hamster dermal cell immortalization is not enhanced by power line frequency electromagnetic field exposure. Br J Cancer (1999) 0.75
A mechanistic evaluation of the Syrian hamster embryo cell transformation assay (pH 6.7) and molecular events leading to senescence bypass in SHE cells. Mutat Res Genet Toxicol Environ Mutagen (2016) 0.75
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med (1996) 3.88
SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet (1998) 3.79
Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol Cell Biol (1988) 2.80
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature (1983) 2.77
B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med (1988) 2.64
Translational activation of the lck proto-oncogene. Nature (1988) 2.41
Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell (1989) 2.40
Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol (1991) 2.36
Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst (1999) 1.73
Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification. Nature (1980) 1.71
Increased viral titer through concentration of viral harvests from retroviral packaging lines. Hum Gene Ther (1993) 1.58
Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res (2001) 1.54
Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest (2000) 1.48
Exceptional mutagenicity of a benzo(a)pyrene diol epoxide in cultured mammalian cells. Nature (1976) 1.40
In vitro effects of ultraviolet A on histamine release from human basophils. J Eur Acad Dermatol Venereol (2003) 1.40
Histologic and hormonal evaluation of the ovarian function in leukemic girls after successful treatment. Pediatr Hematol Oncol (1990) 1.39
T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1. Proc Natl Acad Sci U S A (1989) 1.37
Human acrocentric chromosomes with transcriptionally silent nucleolar organizer regions associate with nucleoli. EMBO J (2001) 1.35
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer (1999) 1.30
Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature (1982) 1.26
SNP subset selection for genetic association studies. Ann Hum Genet (2003) 1.22
A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet (2001) 1.22
Construction and characterization of a highly stable human: rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet (1995) 1.21
The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer (2009) 1.20
WNT5A expression in human breast cancer. Anticancer Res (2005) 1.18
Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res (2001) 1.18
hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol (2003) 1.13
Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis (2009) 1.07
hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat (2003) 1.04
Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene (1997) 1.02
Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line. J Natl Cancer Inst (2001) 0.98
Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 0.97
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. Am J Surg (1999) 0.93
Prospective comparative study of magnetic resonance imaging versus transrectal ultrasound for preoperative staging and follow-up of rectal cancer. Preliminary report. Dis Colon Rectum (1991) 0.92
Telomerase activity and lymphovascular invasion in breast cancer. Eur J Surg Oncol (2000) 0.92
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. Eur J Clin Invest (2004) 0.91
FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus. Clin Genet (2008) 0.91
Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer (1990) 0.91
Clonal growth of murine pre-B colony-forming cells and their targeted infection by a retroviral vector: dependence on interleukin-7. Blood (1990) 0.90
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. Eur J Clin Invest (2001) 0.89
Computed tomography diagnosis of primary aorto-enteric fistula. Clin Imaging (1989) 0.89
Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer (1999) 0.87
Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells. Oncogene (2012) 0.87
Cell-mediated mutagenesis in cultured Chinese hamster cells by carcinogenic polycyclic hydrocarbons: nature and extent of the associated hydrocarbon-DNA reaction. Mutat Res (1977) 0.86
Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients. Eur J Neurol (2008) 0.86
Evidence of a tumour suppressive function of E2F1 gene in human breast cancer. Anticancer Res (2008) 0.86
Benzo(a)pyrene metabolism and DNA adduct formation in serially cultivated strains of human epidermal keratinocytes. Int J Cancer (1980) 0.86
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism. Neurol Sci (2002) 0.86
Inhibition of fertilization in vitro by treatment of rabbit spermatozoa with univalent isoantibody. J Reprod Fertil (1974) 0.85
The cytotoxic, mutagenic and clastogenic effects of chromium-containing compounds on mammalian cells in culture. Mutat Res (1979) 0.85
Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study. Clin Exp Pharmacol Physiol (2009) 0.84
Inhibition of metabolic cooperation between mammalian cells in culture by tumor promoters. Carcinogenesis (1981) 0.84
Identification of human tumour suppressor genes by monochromosome transfer: rapid growth-arrest response mapped to 9p21 is mediated solely by the cyclin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A). Carcinogenesis (1996) 0.84
Lipoblastoma: a case with t(7;8)(q31;q13). Cancer Genet Cytogenet (1998) 0.83
[Pathogenesis of primary lymphedemas]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir (1980) 0.83
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity. Eur J Clin Invest (2004) 0.82
17q21-qter trisomy is an indicator of poor prognosis in acute myelogenous leukemia. Cancer Genet Cytogenet (2001) 0.82
Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod Pathol (1998) 0.82
hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer. Anticancer Res (2007) 0.82
A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene (1998) 0.81
Evidence of a tumour suppressor function for DLEC1 in human breast cancer. Anticancer Res (2010) 0.81
Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol (1992) 0.80
Identification of tumor metastasis suppressor region on the short arm of human chromosome 20. Genes Chromosomes Cancer (2001) 0.80
Localization of a novel tumor metastasis suppressor region on the short arm of human chromosome 2. Genes Chromosomes Cancer (2000) 0.80
Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res (1998) 0.80
Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol Rep (2013) 0.80
The effect of different TP53 mutations on the chromosomal stability of a human colonic adenoma derived cell line with endogenous wild type TP53 activity, before and after DNA damage. Genes Chromosomes Cancer (1997) 0.80
Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene. Cancer Res (1999) 0.80
Mammary-derived growth inhibitor (MDGI) cloned from human breast epithelial cells is expressed in fully differentiated lobular structures. Int J Oncol (1997) 0.80
Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. Cancer Res (1999) 0.80
Telomerase activity and prognosis in breast cancer. Eur J Surg Oncol (1999) 0.79
To be or not to be translational. Transl Med UniSa (2013) 0.79
Multistep malignant transformation of mammalian cells by carcinogens: induction of immortality as a key event. Carcinog Compr Surv (1985) 0.79
Natural history and clinical features of progressive supranuclear palsy: a clinical study. Neurol Sci (2003) 0.79
Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel disease. Eur J Immunogenet (2003) 0.79
Novel use of a selectable fusion gene as an "in-out" marker for studying genetic loss in mammalian cells. Mol Carcinog (1995) 0.79
Telomerase activity in phyllodes tumours. Eur J Surg Oncol (1999) 0.79
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog (2005) 0.78
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. Horm Metab Res (1992) 0.78
In vivo regional delivery of retrovirally mediated foreign genes to rat liver cells: need for partial hepatectomy for successful foreign gene expression. Surgery (1993) 0.78
A quantitative comparison of the mutagenicity of carcinogenic polycyclic hydrocarbon derivatives in cultured mammalian cells. Int J Cancer (1979) 0.78
HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR. Anticancer Res (2007) 0.78